First Once-a-Month Buprenorphine Injection Approved

For the battle to fight opioid addiction and the so-called opioid use disorder (OUD), the FDA has given patients and practitioners another tool.  This once-a-month injection is indicated for OUD for patients on a stable dose of buprenorphine for at least 7 days.  Previous treatments with this drug required daily doses of orally administered products like films or tablets,

Lisa Tinsley, new Director at Lachman Consultant Services, Inc.

We are pleased to announce that Lisa Tinsley has accepted the position of Director in the Compliance Practice at Lachman Consultants, effective December 1, 2017.

Ms. Tinsley is a 25-year pharmaceutical compliance and remediation professional who has led global compliance and auditing teams, developed Quality leadership and strategies, and enhanced Quality Systems. She is well experienced with FDA inspection requirements,

First Once-a-Month Buprenorphine Injection Approved

For the battle to fight opioid addiction and the so-called opioid use disorder (OUD), the FDA has given patients and practitioners another tool.  This once-a-month injection is indicated for OUD for patients on a stable dose of buprenorphine for at least 7 days.  Previous treatments with this drug required daily doses of orally administered products like films or tablets,

12